Epizyme is a biopharmaceutical company based in Cambridge, MA that focuses on developing novel epigenetic therapies for patients with cancer and other serious diseases.
Utilizing their expertise in epigenetics, Epizyme is committed to advancing precision medicine through the discovery and development of targeted therapies that address unmet medical needs.
Generated from their business information